Evidence map›Paper›PMID 41857091›Full record

ArticleScientific reports2026

IL-8 contributes to postoperative adhesion formation through the crosstalk of neutrophils and mesothelial cells.

Kenji Nakagawa, Hiromi Tanimura, Masaki Yamazaki, Izumi Sato, Shinta Kobayashi, Miho Kohara, Yuichiro Sakamoto, Narumi Sakaguchi, Atsuhiko Kato, Masahiro Azuma and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kenji NakagawaResearch Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan. nakagawa.kenji10@chugai-pharm.co.jp.
Hiromi TanimuraResearch Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Masaki YamazakiTranslational Research Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Izumi SatoResearch Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Shinta KobayashiChugai Pharma USA, Inc., 300 Connell Drive, Suite 3100, Berkeley Heights, NJ, 07922, USA.
Miho KoharaTsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, 1-1 Hachimandai, Tsukuba-shi, Ibaraki, 305-0843, Japan.
Yuichiro SakamotoTranslational Research Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Narumi SakaguchiResearch Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Atsuhiko KatoTranslational Research Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Masahiro AzumaResearch Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Ayako Nishimoto-KakiuchiTranslational Research Division, Chugai Pharmaceutical Co. Ltd., 2-1-1 Nihonbashi-Muromachi, Chuo-ku, Tokyo, 103-8324, Japan.
Takehisa KitazawaResearch Division, Chugai Pharmaceutical Co. Ltd., 216 Totsuka-cho, Totsuka-ku, Yokohama, Kanagawa, 244-8602, Japan.
Ryo KonnoDepartment of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-shi, Saitama, 330-8503, Japan. kryo772007@yahoo.co.jp.
Tadashi SankaiTsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, 1-1 Hachimandai, Tsukuba-shi, Ibaraki, 305-0843, Japan. t-sankai@nibn.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postoperative adhesions (PA) remain an untreatable complication of abdominal surgery. In this study, we analyzed the role of interleukin-8 (IL-8) in the formation of PA using human cells in vitro and cynomolgus monkeys in vivo, as rodents lack the IL-8 gene. In an in vitro chemotaxis assay, recombinant IL-8 attracted more human neutrophils than its functional homologue, CXCL1, reflecting the dual engagement of CXCR1/2. In the human mesothelial cell line MeT-5A, IL-8 induced TNF-α secretion, which was abolished by the anti-IL-8 antibody AMY109. Conversely, TNF-α dose-dependently upregulated IL-8, supporting a reciprocal amplification loop. Although IL-8 did not directly alter the expression of fibrotic genes in neutrophils or mesothelial cells, TNF-α upregulated TGFB1 mRNA in neutrophils, linking early IL-8/TNF-α signaling to profibrotic cascades. In monkey PA models, IL-8 in the injured abdominal wall was upregulated at 6 h post-surgery. Prophylactic AMY109 (10 mg/kg, i.v.) reduced the abdominal-wall adhesion score (P < 0.05) and tended to lower uterine adhesions (P = 0.0907). These findings suggest that IL-8 orchestrates neutrophil recruitment and crosstalk between neutrophils and mesothelial cells, amplifying inflammation and fibrosis, and that IL-8 blockade effectively attenuates PA formation. Targeting IL-8 therefore represents a promising pharmacological strategy to prevent PA.

Indexed as

Epithelial CellsInterleukin-8NeutrophilsPostoperative ComplicationsAnimalsCell LineFemaleHumansMacaca fascicularisSignal TransductionTissue AdhesionsTumor Necrosis Factor-alphaInterleukin-8Tumor Necrosis Factor-alpha

Identifiers

PMID41857091
PMCPMC13139559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.